I happen to think the long term future of SIGA is positive. Over the years (since 2006) I have conversed with various infectious disease specialists including DA Henderson about SIGA and its platform. The remarks of most virologists and biochemists with whom I have spoken, corporate leadership and litigation aside, have led me to continue to maintain a position (though not as large as it once was) because of the potential SIGA has already demonstrated through arrestyvr. I am betting the science and their pipeline will develop. With improvement in corporate leadership and the resolution of the PIP litigation I am gambling the investment will be profitable for those who wait.